KSI 601
Alternative Names: KSI-601Latest Information Update: 11 Mar 2022
At a glance
- Originator Kodiak Sciences
- Class Biopolymers; Drug conjugates; Eye disorder therapies; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Dry age-related macular degeneration